Education
About Us
Working with TipRanks
Follow Us
Medline (MDLN)
NASDAQ:MDLN
Total Valuation
Medline has a market cap or net worth of $56.33B. The enterprise value is $45.43B.
Market Cap$56.33B
Enterprise Value$45.43B
Share Statistics
Medline has 811,647,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding811,647,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medline’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.69%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.69%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee661.21K
Profits Per Employee26.95K
Employee Count43,000
Asset Turnover0.74
Inventory Turnover4.39
Valuation Ratios
The current PE Ratio of Medline is 29.4. Medline’s PEG ratio is -4.97.
PE Ratio29.4
PS Ratio1.20
PB Ratio3.18
Price to Fair Value3.18
Price to FCF19.56
Price to Operating Cash Flow19.96
PEG Ratio-4.97
Income Statement
In the last 12 months, Medline had revenue of 28.43B and earned 1.16B in profits. Earnings per share was 1.43.
Revenue28.43B
Gross Profit7.52B
Operating Income2.21B
Pretax Income1.25B
Net Income1.16B
EBITDA2.92B
Earnings Per Share (EPS)1.43
Cash Flow
In the last 12 months, operating cash flow was 1.74B and capital expenditures 0.00, giving a free cash flow of 1.74B billion.
Operating Cash Flow1.74B
Free Cash Flow1.74B
Free Cash Flow per Share2.15
Dividends & Yields
Medline pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.72
52-Week Price Change4.59%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)8.56M
Important Dates
Medline upcoming earnings date is Feb 25, 2026, Before Open (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateFeb 25, 2026
Ex-Dividend Date―
Financial Position
Medline as a current ratio of 4.29, with Debt / Equity ratio of 116.99%
Current Ratio4.29
Quick Ratio2.37
Debt to Market Cap0.37
Net Debt to EBITDA3.64
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medline has paid 91.00M in taxes.
Income Tax91.00M
Effective Tax Rate0.07
Enterprise Valuation
Medline EV to EBITDA ratio is 15.34, with an EV/FCF ratio of 25.65.
EV to Sales1.57
EV to EBITDA15.34
EV to Free Cash Flow25.65
EV to Operating Cash Flow25.65
Balance Sheet
Medline has $1.94B in cash and marketable securities with $12.56B in debt, giving a net cash position of -$10.62B billion.
Cash & Marketable Securities$1.94B
Total Debt$12.56B
Net Cash-$10.62B
Net Cash Per Share-$13.09
Tangible Book Value Per Share-$3.31
Margins
Gross margin is 24.58%, with operating margin of 7.78%, and net profit margin of 4.08%.
Gross Margin24.58%
Operating Margin7.78%
Pretax Margin4.39%
Net Profit Margin4.08%
EBITDA Margin10.26%
EBIT Margin7.78%
Analyst Forecast
The average price target for Medline is $52.35, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$52.35
Price Target Upside17.50% Upside
Analyst ConsensusStrong Buy
Analyst Count27
Revenue Growth Forecast―
EPS Growth Forecast―